Published in Chromosoma on January 01, 1988
Mitotic silencing of human rRNA synthesis: inactivation of the promoter selectivity factor SL1 by cdc2/cyclin B-mediated phosphorylation. EMBO J (1998) 2.01
The yeast NOP4 gene product is an essential nucleolar protein required for pre-rRNA processing and accumulation of 60S ribosomal subunits. EMBO J (1994) 1.73
Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA. Proc Natl Acad Sci U S A (1993) 1.60
A possible mechanism for the inhibition of ribosomal RNA gene transcription during mitosis. J Cell Biol (1995) 1.51
In vitro assembly of prenucleolar bodies in Xenopus egg extract. J Cell Biol (1992) 1.31
FACT facilitates chromatin transcription by RNA polymerases I and III. EMBO J (2009) 1.23
Preferential binding of human topoisomerase I to superhelical DNA. EMBO J (1995) 1.19
Organization of small nucleolar ribonucleoproteins (snoRNPs) by fluorescence in situ hybridization and immunocytochemistry. Mol Biol Cell (1994) 1.19
Nucleolar adaptation in human cancer. Cancer Invest (2005) 1.13
Eukaryotic topoisomerase I-DNA interaction is stabilized by helix curvature. Nucleic Acids Res (1991) 1.05
Interaction between the N-terminal domain of human DNA topoisomerase I and the arginine-serine domain of its substrate determines phosphorylation of SF2/ASF splicing factor. Nucleic Acids Res (1998) 1.00
Basic mechanisms in RNA polymerase I transcription of the ribosomal RNA genes. Subcell Biochem (2013) 0.94
Negative regulation of mitochondrial transcription by mitochondrial topoisomerase I. Nucleic Acids Res (2013) 0.90
Topoisomerase I is preferentially associated with normal SV40 replicative intermediates, but is associated with both replicating and nonreplicating SV40 DNAs which are deficient in histones. Nucleic Acids Res (1992) 0.82
Topoisomerase IIα promotes activation of RNA polymerase I transcription by facilitating pre-initiation complex formation. Nat Commun (2013) 0.81
Mutational analysis of the preferential binding of human topoisomerase I to supercoiled DNA. FEBS J (2009) 0.81
Topoisomerase I inhibitors and drug resistance. Cytotechnology (1998) 0.78
Evolution of repeated sequences in the ribosomal DNA intergenic spacer of 32 arthropod species. J Mol Evol (2010) 0.78
Antisense oligonucleotides as therapeutic agents--is the bullet really magical? Science (1993) 5.50
Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues. Proc Natl Acad Sci U S A (1991) 3.82
Deoxythymidine kinase induced in HeLa TK- cells by herpes simplex virus type I and type II. II. Purification and characterization. J Biol Chem (1976) 3.44
The nuclear envelope and the architecture of the nuclear periphery. J Cell Biol (1981) 3.34
Dynamics of gene expression revealed by comparison of serial analysis of gene expression transcript profiles from yeast grown on two different carbon sources. Mol Biol Cell (1999) 3.30
ARSACS, a spastic ataxia common in northeastern Québec, is caused by mutations in a new gene encoding an 11.5-kb ORF. Nat Genet (2000) 3.17
CORRELATED SELECTION FOR MOTILITY AND SEX-INCOMPATIBILITY IN Escherichia Coli K12. Proc Natl Acad Sci U S A (1957) 2.89
Human deoxythymidine kinase. I. Purification and general properties of the cytoplasmic and mitochondrial isozymes derived from blast cells of acute myelocytic leukemia. J Biol Chem (1976) 2.78
The 46/50 kDa phosphoprotein VASP purified from human platelets is a novel protein associated with actin filaments and focal contacts. EMBO J (1992) 2.58
Prophylactic vancomycin to prevent staphylococcal septicaemia in very-low-birth-weight infants. Lancet (1992) 2.56
Localization of RNA polymerase I in interphase cells and mitotic chromosomes by light and electron microscopic immunocytochemistry. Proc Natl Acad Sci U S A (1984) 2.56
In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to non-nucleoside inhibitors of reverse transcriptase. Mol Pharmacol (1992) 2.55
Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1. Proc Natl Acad Sci U S A (1983) 2.54
Microinjection of actin-binding proteins and actin antibodies demonstrates involvement of nuclear actin in transcription of lampbrush chromosomes. Cell (1984) 2.45
Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J (2000) 2.42
The deoxyribonuclease induced after infection of KB cells by herpes simplex virus type 1 or type 2. I. Purification and characterization of the enzyme. J Biol Chem (1978) 2.39
Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2',3'-dideoxycytidine. J Biol Chem (1989) 2.38
Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases. Antimicrob Agents Chemother (1981) 2.34
Inhibition of purified human and herpes simplex virus-induced DNA polymerases by 9-(2-hydroxyethoxymethyl)guanine triphosphate. Effects on primer-template function. J Biol Chem (1981) 2.29
Antiviral action and cellular toxicity of four thymidine analogues: 5-ethyl-,5-vinyl-, 5-propyl-, and 5-allyl-2'- deoxyuridine. Antimicrob Agents Chemother (1976) 2.27
Identification of amino acids in herpes simplex virus DNA polymerase involved in substrate and drug recognition. Proc Natl Acad Sci U S A (1988) 2.27
Metabolism and mechanism of action of 5-fluorouracil. Pharmacol Ther (1990) 2.26
Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Eur Heart J (1999) 2.24
Inhibition of nuclear accumulation of karyophilic proteins in living cells by microinjection of the lectin wheat germ agglutinin. Exp Cell Res (1988) 2.20
Deoxycytidine deaminase-resistant stereoisomer is the active form of (+/-)-2',3'-dideoxy-3'-thiacytidine in the inhibition of hepatitis B virus replication. J Biol Chem (1992) 2.13
Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro. Antimicrob Agents Chemother (1983) 2.09
Autoantibody to RNA polymerase I in scleroderma sera. J Clin Invest (1987) 1.99
A rational approach to the development of antiviral chemotherapy: alternative substrates of herpes simplex virus Type 1 (HSV-1) and Type 2 (HSV-2) thymidine kinase (TK). Ann N Y Acad Sci (1977) 1.96
Differential affinities of 5-(2-halogenovinyl)-2'-deoxyuridines for deoxythymidine kinases of various origins. Mol Pharmacol (1981) 1.94
Human immunodeficiency virus reverse transcriptase. General properties and its interactions with nucleoside triphosphate analogs. J Biol Chem (1987) 1.94
Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. Mol Pharmacol (1991) 1.92
Human immunodeficiency virus reverse transcriptase-associated RNase H activity. J Biol Chem (1989) 1.92
The major polypeptides of the nuclear pore complex. Exp Cell Res (1978) 1.91
Biochemical pharmacology of (+)- and (-)-2',3'-dideoxy-3'-thiacytidine as anti-hepatitis B virus agents. J Biol Chem (1992) 1.91
Immunolocalization of 7-2-ribonucleoprotein in the granular component of the nucleolus. Exp Cell Res (1988) 1.87
Cofactor requirements for nuclear export of Rev response element (RRE)- and constitutive transport element (CTE)-containing retroviral RNAs. An unexpected role for actin. J Cell Biol (2001) 1.86
Influence of oxygen and culture media on plating efficiency of some mammalian tissue cells. J Natl Cancer Inst (1972) 1.86
Population history and its impact on medical genetics in Quebec. Clin Genet (2005) 1.85
Deoxythymidine kinase induced in the HELA TK- cells by herpes simplex virus type I and type II. Substrate specificity and kinetic behavior. Biochim Biophys Acta (1976) 1.85
Ribocharin: a nuclear Mr 40,000 protein specific to precursor particles of the large ribosomal subunit. Cell (1985) 1.84
Association of Epstein-Barr virus early antigen diffuse component and virus-specified DNA polymerase activity. J Virol (1987) 1.84
The ultrastructure of the nuclear envelope of amphibian oocytes: a reinvestigation. I. The mature oocyte. J Ultrastruct Res (1970) 1.83
Identification of a soluble precursor complex essential for nuclear pore assembly in vitro. Chromosoma (1990) 1.82
Lengths and patterns of transcriptional units in the amplified nucleoli of oocytes of Xenopus laevis. Chromosoma (1977) 1.82
Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repeat expansion. Ann Neurol (1997) 1.79
Interaction of herpes simplex virus-induced DNA polymerase with 9-(1,3-dihydroxy-2-propoxymethyl)guanine triphosphate. J Biol Chem (1984) 1.77
The Friedreich ataxia GAA triplet repeat: premutation and normal alleles. Hum Mol Genet (1997) 1.77
Characterization of SAF-A, a novel nuclear DNA binding protein from HeLa cells with high affinity for nuclear matrix/scaffold attachment DNA elements. EMBO J (1992) 1.75
Selective inhibition of herpes simplex virus by 5-amino-2,5-dideoxy-5-iodouridine. J Virol (1975) 1.72
Properties of herpes simplex virus type 1 and type 2 DNA polymerase. Biochim Biophys Acta (1980) 1.71
GAA instability in Friedreich's Ataxia shares a common, DNA-directed and intraallelic mechanism with other trinucleotide diseases. Mol Cell (1998) 1.68
Cellular metabolism of 2',3'-dideoxycytidine, a compound active against human immunodeficiency virus in vitro. J Biol Chem (1987) 1.66
Genetic homogeneity at the Friedreich ataxia locus on chromosome 9. Am J Hum Genet (1989) 1.66
Antiviral activity of 2',3'-dideoxy-beta-L-5-fluorocytidine (beta-L-FddC) and 2',3'-dideoxy-beta-L-cytidine (beta-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro. Biochem Pharmacol (1994) 1.66
(Z)- and (E)-2-((hydroxymethyl)cyclopropylidene)methyladenine and -guanine. New nucleoside analogues with a broad-spectrum antiviral activity. J Med Chem (1998) 1.61
Individual variations of platelet inhibition after loading doses of clopidogrel. J Intern Med (2002) 1.58
Uracil DNA-glycosylase. Purification and properties of this enzyme isolated from blast cells of acute myelocytic leukemia patients. J Biol Chem (1980) 1.57
Experimental disintegration of the nuclear envelope. Evidence for pore-connecting fibrils. J Cell Biol (1976) 1.55
Metabolism of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new anti-herpes virus compound, in herpes simplex virus-infected cells. J Biol Chem (1983) 1.55
Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology. Mol Pharmacol (1992) 1.52
A possible mechanism for the inhibition of ribosomal RNA gene transcription during mitosis. J Cell Biol (1995) 1.51
Inhibition of nucleolar reformation after microinjection of antibodies to RNA polymerase I into mitotic cells. J Cell Biol (1987) 1.51
Potential savings in the cost of caring for Alzheimer's disease. Treatment with rivastigmine. Pharmacoeconomics (2000) 1.48
Conformational difference between nuclear and cytoplasmic actin as detected by a monoclonal antibody. J Cell Sci (1999) 1.48
Experimental observation of the topological structure of exceptional points. Phys Rev Lett (2001) 1.44
Identification of antisense RNA transcripts from a human DNA topoisomerase I pseudogene. Cancer Res (1992) 1.43
Inhibition of hepatitis B virus by a novel L-nucleoside, 2'-fluoro-5-methyl-beta-L-arabinofuranosyl uracil. Antimicrob Agents Chemother (1996) 1.42
Spontaneous assembly of pore complex-containing membranes ("annulate lamellae") in Xenopus egg extract in the absence of chromatin. J Cell Biol (1991) 1.41
DNase induced after infection of KB cells by herpes simplex virus type 1 or type 2. II. Characterization of an associated endonuclease activity. J Virol (1979) 1.40
Nucleic-acid-binding properties of hnRNP-U/SAF-A, a nuclear-matrix protein which binds DNA and RNA in vivo and in vitro. Eur J Biochem (1994) 1.40
Doppler myocardial imaging in the assessment of regional myocardial function in longitudinal direction pre- and post-PTCA. Eur J Echocardiogr (2001) 1.39
The effect of wavelet and discrete cosine transform compression of digital radiographs on the detection of subtle proximal caries. ROC analysis. Caries Res (2008) 1.39
Role of additional mutations outside the YMDD motif of hepatitis B virus polymerase in L(-)SddC (3TC) resistance. Biochem Pharmacol (1998) 1.39
A member of a gene family on Xp22.3, VCX-A, is deleted in patients with X-linked nonspecific mental retardation. Am J Hum Genet (2000) 1.39
Changes of nucleosome frequency in nucleolar and non-nucleolar chromatin as a function of transcription: an electron microscopic study. Cell (1978) 1.38
Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus. Antimicrob Agents Chemother (1995) 1.38
Jac1, a mitochondrial J-type chaperone, is involved in the biogenesis of Fe/S clusters in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (2001) 1.37
Induction of thymidine kinase and DNase in varicella-zoster virus-infected cells and kinetic properties of the virus-induced thymidine kinase. J Virol (1979) 1.33
Anti-herpes simplex virus and anti-human cell growth activity of E-5-propenyl-2'-deoxyuridine and the concept of selective protection in antivirus chemotherapy. Antimicrob Agents Chemother (1980) 1.32
Demonstration of a high affinity folate binder in human cell membranes and its characterization in cultured human KB cells. J Biol Chem (1979) 1.32
Deficit of striatal parvalbumin-reactive GABAergic interneurons and decreased basal ganglia output in a genetic rodent model of idiopathic paroxysmal dystonia. J Neurosci (2000) 1.32
In vitro assembly of prenucleolar bodies in Xenopus egg extract. J Cell Biol (1992) 1.31
Pathways of nucleocytoplasmic translocation of ribonucleoproteins. Symp Soc Exp Biol (1974) 1.31
Properties of purified enzymes induced by pathogenic drug-resistant mutants of herpes simplex virus. Evidence for virus variants expressing normal DNA polymerase and altered thymidine kinase. J Biol Chem (1983) 1.31
An X-linked gene affecting mouse cell DNA synthesis also affects production of unintegrated linear and supercoiled DNA of murine leukemia virus. Mol Cell Biol (1984) 1.30
Localization of ribosomal protein S1 in the granular component of the interphase nucleolus and its distribution during mitosis. J Cell Biol (1985) 1.29
Functional dissociation between medial and lateral prefrontal cortical spatiotemporal activation in negative and positive emotions: a combined fMRI/MEG study. Cereb Cortex (2000) 1.29
Induction of uracil-DNA glycosylase and dUTP nucleotidohydrolase activity in herpes simplex virus-infected human cells. J Biol Chem (1981) 1.28
Synthesis and biological evaluation of 2',3'-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV). J Med Chem (1994) 1.28
Effects of fish oil on rectal cell proliferation, mucosal fatty acids, and prostaglandin E2 release in healthy subjects. Gastroenterology (1993) 1.27
The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in severe asthma. Clin Exp Allergy (2003) 1.25
Ultrastructure of the nuclear envelope of amphibian oocytes. IV. Chemical nature of the nuclear pore complex material. Z Zellforsch Mikrosk Anat (1972) 1.24
HIV-1 reverse transcriptase inhibition by a dipyridodiazepinone derivative: BI-RG-587. Biochem Pharmacol (1992) 1.22
The role of cytoplasmic deoxycytidine kinase in the mitochondrial effects of the anti-human immunodeficiency virus compound, 2',3'-dideoxycytidine. J Biol Chem (1992) 1.22